期刊文献+

盐酸吉西他滨的合成路线图解

Graphical synthetic routes of gemcitabine hydrochloride
下载PDF
导出
摘要 吉西他滨具有抗瘤谱广、毒副反应低等特点,被广泛应用于各种实体肿瘤的治疗,尤其是对胰腺癌和非小细胞肺癌有显著的疗效。公开报道的吉西他滨的合成路线多且杂,因此,很有必要将其合成路线进行归纳整理,方便人们查阅以及做出相应的工艺优化。 Gemcitabine,which has wide anti -tumor spectrum and little side -effects, is widely used in the treatment of solid tumors, especially pancreatic cancer and non - small cell lung cancer. The synthesis routes of gemcitabine were miscellaneous. Therefore, it was necessary to analyze the synthetic routes for its convenient consulting and further optimization.
出处 《齐鲁药事》 2012年第10期608-610,614,共4页 qilu pharmaceutical affairs
关键词 吉西他滨 抗肿瘤 合成路线 Gemcitabine Anti - tumor Synthetic routes
  • 相关文献

参考文献14

  • 1郭冬梅,李冲.吉西他滨临床应用进展[J].中国中医药现代远程教育,2011,9(13):154-156. 被引量:15
  • 2de Alvarenga ES, Carneiro VM, Sihverio FO, et al. A high yield synthesis of 1,2 : 5,6 - di - 0 - isopropylidene - D - mannitol [ J ]. J Chil Chem Soc, 2006,51 ( 3 ) : 986 - 988.
  • 3Schmid CR, Bryant JD, Dowlatzedah M, et al. Synthesis of 2,3 - 0 - isopropylidene - D - glyceraldehydes in high chemical and optical purity:observations on the develop- ment of a practical bulk process [ J ]. J Org Chem, 1991,56 (12) :4056 -4058.
  • 4Kuszmann J, Tomori, Meerwald I. The synthesis of ! , 2 : 5, 6 - di - 0 - isopropylidene - D - mannitol : a comparative study [ J ].Carbohydr Res, 1984,128 ( 1 ) : 87 - 99.
  • 5Schmid CR, Bryant JD. D - (R) - glyceraldehyde ace- tonide[J]. Organic Syntheses, 1998,9:450 - 454.
  • 6LEE J, PARK GS, Lee M,et al. Method [br the preparation of D - erythro - 2,2 - difluoro - 2 - deoxy - 1 - oxori- bose derivative ~ WO .2006009353A1 [ P ]. 2006 - 01- 26.
  • 7Chou TS, Heath PC, Patterson LM, et al. Stereospecific synthesis of 2 -deoxy -2,2 -difluororibonolactone and its use in the preparation of 2' -deoxy -2', 2' -difluoro - [3 - D - libothranosylpyrimidine nucleosides : the key role of selective crystallization [ J ]. Synthesis, 1992, 1992 (6) : 565 - 570.
  • 8王英华,王星海,仇缀百.盐酸吉西他滨的合成[J].中国医药工业杂志,2007,38(4):249-251. 被引量:15
  • 9林国强,蒋昌盛.新型抗癌药吉西他宾重要中间体新合成工艺:中国,1229372C[P].2005-11-30.
  • 10Polturi RB,Venkata SH, Betini R. An improved process for the manufacture of high pure gemcitabine hydroch|oride: WO ,2005095430A1 [ P]. 2005 - 10 - 13.

二级参考文献32

  • 1叶萍,李兆申,张文俊,刘枫,施新岗.吉西他滨肝动脉灌注治疗晚期肝癌[J].第二军医大学学报,2006,27(10):1154-1156. 被引量:10
  • 2霍伟,曲范杰,范丽昕,张咏梅,李萍.吉西他滨联合卡铂一线治疗晚期非小细胞肺癌疗效观察[J].临床肿瘤学杂志,2006,11(11):828-829. 被引量:14
  • 3Seidman AD.Gemcitabine as single-agent therapy in the management of advanced breast cancer[J].Oncology(Williston Park).ONCOLOGY 2001,15(2Suppl 3):11-4.
  • 4K.S.Albain,S.Nag,G.Calderillo-Ruiz,et al.Global phase III study of gemcitabine plus paclitaxel(GT) vs.paclitaxel(T) as frontline therapy for metastatic breast cancer(MBC):First report of overall surviva[J].Journal of Clinical Oncology,2004 ASCO Annual Meeting Proceedings(Post-Meeting Edition).Vol 22,No 14S(July 15Supplement),2004:510.
  • 5Jacobus Pfisterer,Marie Plante,Ignace Vergote,et al.Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With PlatinumSensitive Recurrent Ovarian Cancer:An IntergrouPTrial of the AGO-OVAR,the NCIC CTG,and the EORTC GCG[J].J Clin Oncol 2006,24:4699-4707.
  • 6Brewer CA,Blessing JA,Nagourney RA,McMeekin DS,Lele S,Zweizig SL.Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix:a phase Ⅱ study of the Gynecologic Oncology Group[J].Gynecol Oncol.2006,100(2):385-8.
  • 7David G.Mutch,Mauro Orlando,Tiana Goss,et al.Randomized Phase Ⅲ Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer[J].J Clin Oncol 2007,25:2811-2818.
  • 8Gabriella Ferrandina,Manuela Ludovisi,Domenica Lorusso,et al.Phase Ⅲ Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer.J Clin Oncol 2008,26:890-896.
  • 9Martee L.Hensley,John A.Blessing,Robert Mannel,and Peter G.Rose.Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma:a Gynecologic Oncology GrouPphase Ⅱ trial[J].Gynecol Oncol.2008 June,109(3):329-334.
  • 10Look Katherine Y ;Sandler Alan ;Blessing John A,et al.Phase Ⅱ trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma:a Gynecologic Oncology Group(GOG) Study[J].Gynecologic oncology 2004,92(2):644-7.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部